Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5

Alex von Kriegsheim1, Andrew Pitt, G Joan Grindlay

  • 1The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Nature Cell Biology
|August 8, 2006
PubMed

Insights

Protein phosphatase 5 (PP5) inactivates the Raf-1 kinase, a key component of the Raf-MEK-ERK pathway. PP5 selectively dephosphorylates an activating site on Raf-1, inhibiting downstream signaling and cell fate decisions.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Signal transduction

Background:

  • The Raf-MEK-ERK pathway is crucial for cell fate decisions, responding to growth factor and extracellular matrix signals.
  • Raf-1 is the initiating kinase in this cascade, directly activated by Ras GTPase.
  • Mechanisms of Raf-1 inactivation remain largely uncharacterized.

Purpose of the Study:

  • To identify molecules that inactivate Raf-1 signaling using a proteomic approach.
  • To elucidate the role of identified molecules in regulating Raf-1 activity.

Main Methods:

  • Proteomic analysis to identify Raf-1 interacting proteins.
  • Biochemical assays to assess dephosphorylation activity.
  • Site-directed mutagenesis to investigate specific phosphorylation sites (Ser 338).
  • Cellular experiments involving PP5 depletion and phosphomimetic substitutions.

Main Results:

  • Protein phosphatase 5 (PP5) was identified as a Raf-1 inactivator.
  • PP5 selectively dephosphorylates the activating site Ser 338 on Raf-1 upon growth factor stimulation.
  • PP5-mediated dephosphorylation inhibits Raf-1 activity and downstream MEK signaling.
  • Inhibition was reversed by phosphomimetic substitution or loss of PP5 catalytic function.
  • PP5 depletion increased cellular phospho-Ser 338 levels, confirming its role.

Conclusions:

  • PP5 acts as a physiological regulator of Raf-1 signaling.
  • PP5 deactivates the Raf-MEK-ERK pathway by targeting the Ser 338 site on Raf-1.
  • Understanding PP5's role provides insights into controlling cell growth and fate.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...